Schivo Expands Capabilities with Mecaplast Acquisition
Strategic Acquisition Enhances Schivo's Position
Strategic Acquisition Expands Schivo's in Precision Plastics, Metal and Ceramic Injection Molding Capabilities for MedTech and Life Sciences
Schivo is thrilled to share that it has successfully acquired Mecaplast SA, renowned for its expertise in high-precision injection-molded plastics, metals, and ceramics tailored for medical devices and life sciences. This acquisition significantly enhances Schivo's capabilities and deepens its role as a pivotal partner in the dynamic MedTech and Life Sciences sectors.
Empowering the Future of MedTech
Founded in 1971, Mecaplast has set a standard of excellence from its base in Botterens, Switzerland, consistently providing critical components, precision molds, and cleanroom assemblies for industry leaders in the MedTech and Life Sciences domains. With over 64,000 sq. ft. of space dedicated to production and certified under ISO 13485, Mecaplast excels in areas such as micro-molding and automation.
The recent acquisition is a strategic move that strengthens Schivo's vertical integration. By adding capabilities in plastics, metals, and ceramics, Schivo is set to introduce a European center of excellence. This hub will leverage advanced plastics and metal injection molding technologies to support MedTech and Life Sciences operations across the U.S. and Mexico, addressing critical needs in international markets.
Statements from Leadership
Graham Reeves, CEO of Schivo, remarked, "Mecaplast brings decades of deep expertise in complex materials, which aligns perfectly with our vision to foster a global multi-capability platform for advanced medical and Life Sciences devices, focusing on robotic and minimally invasive surgical technologies. Their commitment to innovation greatly boosts our integrated solutions across various sectors and markets."
Jean-Marc Jaccottet, CEO and Owner of Mecaplast, expressed enthusiasm about the partnership, stating, "Joining Schivo represents a natural evolution for Mecaplast SA. We are eager to continue serving our long-standing customers while also reaching out to new clients. This collaboration accelerates investments and enhances our capacity, enabling us to expand our Swiss excellence in precision injection molding and innovative manufacturing."
Future Developments
The Mecaplast facility will become Schivo's Global Center of Excellence, focusing on molding precision in plastics, metals, and ceramics. Jean-Marc Jaccottet will lead as President of Molding Technologies within Schivo's leadership team, overseeing research and development initiatives that will drive growth and innovation within the advanced molding solutions space.
About Schivo
Schivo is committed to shaping the future of medical and life science devices. By partnering with innovators and leaders in the Medical Device and Life Sciences fields, they develop, manufacture, and deliver prototypes and finished devices. Schivo acts as an extension of clients' development teams, tackling unique engineering challenges, enhancing manufacturing processes, and streamlining the supply chain from concept to market launch.
Frequently Asked Questions
What is the significance of Schivo's acquisition of Mecaplast?
The acquisition expands Schivo's capabilities in precision molding and enhances its position in MedTech and Life Sciences, allowing for more advanced product offerings.
What expertise does Mecaplast bring to Schivo?
Mecaplast brings decades of experience in creating high-precision injection-moulded components and assemblies for medical devices and life sciences.
How will the acquisition impact Schivo's operations?
The acquisition will enhance vertical integration and support Schivo’s manufacturing capabilities across global markets, particularly in the U.S. and Mexico.
Who will lead the new initiatives in molding technologies at Schivo?
Jean-Marc Jaccottet will join the Schivo leadership team as President of Molding Technologies, driving innovation and capacity growth following the acquisition.
What is Schivo's overall mission?
Schivo aims to address engineering challenges and streamline processes in the development and manufacturing of medical and life science devices, supporting their clients effectively throughout their product journeys.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.